About Erectile Dysfunction
Viagra, Cialis, and Levitra had total revenues of $4 billion in 2012 for their respective companies, despite the fact that these medications only help half of all men and can have very unpleasant and potentially dangerous side effects.
Many men with mild ED, or even some with no ED symptoms at all, take these medications simply as supplements to ensure strong sexual performance.
Men with severe ED are candidates for micro-penile injections comprised of three or four vasodilators. These medications have no side effects as compared to the oral varieties.
There is now a potential cure available. Our revolutionary Acoustic Wave Therapy Protocol uses acoustical pulse waves to open existing blood vessels, grow new blood vessels, and stimulate stem cells to grow new erectile tissue (corpus cavernosum) in the penis.
Depending on a man’s overall health and preexisting conditions, this noninvasive treatment option will greatly improve erectile dysfunction and performance.
Independent, published research papers have proven its safety and efficacy, with 86% of men saying they would recommend it to a friend.
We believe that this could actually roll back the clock for most men, allowing men of ages up to 80 — or even 90 — to perform as they did in their more virile years.
Clinical Research for ED
Shockwave Treatment Of
Erectile Dysfunction
LI-ESWT is a revolutionary treatment of ED, and probably possesses unprecedented qualities that can rehabilitate erectile tissue. The clinical improvement in subjective erectile function together with the significant improvement in penile hemodynamics following LI-ESWT confirm that LI-ESWT has unique properties that may create a new standard of care for men with ED.
LI-ESWT is both feasible and tolerable and without any adverse or unwanted effects. Its main advantage is its ability to improve and potentially restore erectile function in men with ED without additional pharmacotherapy. Hence, LI-ESWT is an appealing addition to the armamentarium of existing treatment options for ED. In the near future, we hope that LI-ESWT will be used for the long-term clinical management of ED either as an alternative or as an enhancer to the current treatments of ED.
INTERNATIONAL JOURNAL OF ANDROLOGY
Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie’s disease and erectile dysfunction: results from a prospective randomized trial
THE CANADIAN JOURNAL OF UROLOGY
Low-intensity extracorporeal shockwave therapy for erectile dysfunction: a study in an Indian population
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
Efficiency Assessment of Shock Wave Therapy in Patients with Pelvic Pain Employing Harmonic Analysis of Penile Bioimpedance
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH
Initial experience with linear focused shockwave treatment for erectile dysfunction: a 6-month follow-up pilot study
EUROPEAN ASSOCIATION OF UROLOGY
Low-intensity Extracorporeal Shock Wave Treatment Improves Erectile Function: A Systematic Review and Meta-analysis
INTERNATIONAL SOCIETY FOR SEXUAL MEDICINE
Low Intensity Extracorporeal Shock Wave Therapy—A Novel Effective Treatment for Erectile Dysfunction in Severe ED Patients Who Respond Poorly to PDE5 Inhibitor Therapy
EUROPEAN UROLOGY VARDI
Can Low Intensity Extracorporeal Shockwave Therapy Improve Erectile Function? A 6-Month Follow-up Pilot Study in Patients with Organic Erectile Dysfunction
EUROPEAN UROLOGY MIRONE
Our Experience on the Association of a New Physical and Medical Therapy in Patients Suffering from Induratio penis plastica
INTERNATIONAL JOURNAL OF UROLOGY
Impact of aging and comorbidity on the efficacy of low-intensity shock wave therapy for erectile dysfunction
BJU INTERNATIONAL
Peyronie’s disease the Plymouth experience of extracorporeal shockwave treatment
THE JOURNAL OF UROLOGY
Penile Low Intensity Shock Wave Treatment is Able to Shift PDE5i Nonresponders to Responders: A Double-Blind, Sham Controlled Study
AMERICAN SOCIETY OF ANDROLOGY AND EUROPEAN ACADEMY OF ANDROLOGY
Therapeutic advances in the treatment of Peyronie’s disease
THE AUTHORS – BJU INTERNATIONAL
Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian first open-label single-arm prospective clinical trial
MEDCRAVE
Men’s Power-Pressure Wave Erectile Regeneration-Therapy
Come stop by!